Docs | NCODA

You are viewing all docs.

Title	Author	Created	Last Edited	Group
2020 NCODA Oral Oncolytic Prescribing and Expenditure Trends Read Attachments 2020-NCODA-Oral-Oncolytic-Prescribing-and-Expenditure-Trends-v3.pdf	Victoria	March 18, 2020	March 18, 2020	Presentations
2020 Oral Oncolytic Drug Update Read Attachments 2020-Oral-Oncolytic-Drug-Update.pdf	Victoria	November 13, 2020	November 13, 2020	Presentations
Accreditation Options, Issues, Processes, and Cost Read Attachments accreditationoptionsissuesprocessescostsncoda2017.pdf	Janelle	March 20, 2017	July 20, 2018	Presentations
ADHERENCE ASSESSMENT: IDENTIFYING AND ADDRESSING POTENTIAL BARRIERS Kathy W. Oubre, MS Jody Pelusi, PhD, FNP, AOCNP Kristine B. LeFebvre, MSN, RN, AOCN Read Attachments FRI-Murano-3PM-2018-NCODA-Fall-Summit_Adherence-Assessment-Identifying-and-Addressing-Potential-Barriers.pdf	Victoria	October 29, 2018	October 29, 2018	Presentations
Advances in Managing Metastatic Non-small Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors Eve Segal, PharmD, BCOP Lead Clinical Pharmacist, Hematology/Oncology Seattle Cancer Care Alliance Seattle, Washington Read Attachments NSCLC-Checkpoint-Inhibitors_Segal_PTCE-NCODA_Final-for-Handout-002.pdf	Victoria	October 26, 2020	October 26, 2020
There are no docs for this view.

Viewing 1-5 of 175 docs

1 2 3 … 34 35 »